Clinical trial · Interventional
Thrombocytopenia Induced by Chemotherapy
A Post Marketing Randomized Placebo Controlled Study to Evaluate the Efficacy of Study Product UPLAT® (Carica Papaya Leaf Extract + Tinospora Cardifolia Extract) in the Cancer Patients With Thrombocytopenia Induced by Chemotherapy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Single blind, randomized, multicentric placebo controlled study to evaluate the efficacy of Study product in patient with Chemotherapy induced thrombocytopenia. The Study is divided into \[screening visit (visit 1) \> baseline and treatment allocation visit (visit 2) \>blood collection (visit 3); treatment compliance visit (visit 4) \> blood collection (visit 5) \>blood collection (visit 6)\>end of study visit (visit 7)\].
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Thrombocytopenia | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Placebo | Other | — | UNRESOLVED |
| UPLAT | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- A
- description
- UPLAT® (Carica papaya leaf Extract + Tinospora cardifolia Extract Take 4 units daily (2 in morning and 2 in evening) for 10 days
- interventionNames
- Dietary Supplement: UPLAT
- type
- PLACEBO_COMPARATOR
- label
- B
- description
- Placebo Take 4 units daily (2 in morning and 2 in evening) for 10 days
- interventionNames
- Other: Placebo
Primary outcomes (1)
- measure
- Increase in the platelet counts from baseline levels to the end of therapy.
- timeFrame
- Day 15
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 55 Years
Show eligibility criteria text
Inclusion Criteria: 1. Male or female aged between 18-55 years. 2. Subjects must sign with date an informed consent prior to any evaluation and participation in the trial. 3. Patients who were confirmed solid tumour and received at least one cycle of chemotherapy prior to screening visit. 4. Patients with a platelet counts between \> 20000 and \< 150,000/ml at the time of screening. Exclusion Criteria: 1. Planning to receive any type of surgery. 2. Pregnant or lactating women. 3. Patients with platelet count less than 20000/ml. 4. Patients with thrombocytopenia presenting with active bleeding. 5. Patients who have received blood or blood product transfusion during the current illness or during past one week. 6. Patients with thrombocytopenia purpura (ITP) leukemia, hemophilia or bleeding diathesis. 7. Participation in another trial with another investigational product
References
Publications (0)
Data not yet available